PubRank

C Selleri

Author PubWeight™ 38.78‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Fas antigen expression on CD34+ human marrow cells is induced by interferon gamma and tumor necrosis factor alpha and potentiates cytokine-mediated hematopoietic suppression in vitro. Blood 1995 1.85
2 67 kDa laminin receptor: structure, function and role in cancer and infection. Infez Med 2012 1.46
3 Extramedullary involvement at relapse in acute promyelocytic leukemia patients treated or not with all-trans retinoic acid: a report by the Gruppo Italiano Malattie Ematologiche dell'Adulto. J Clin Oncol 2001 1.43
4 Increased expression of Fas antigen on bone marrow CD34+ cells of patients with aplastic anaemia. Br J Haematol 1995 1.27
5 A severe and consistent deficit in marrow and circulating primitive hematopoietic cells (long-term culture-initiating cells) in acquired aplastic anemia. Blood 1996 1.24
6 Accelerated bone mass senescence after hematopoietic stem cell transplantation. Transl Med UniSa 2013 1.13
7 Interferon-alpha induces apoptosis in human KB cells through a stress-dependent mitogen activated protein kinase pathway that is antagonized by epidermal growth factor. Cell Death Differ 1999 1.13
8 Inhibition of interferon regulatory factor-1 expression results in predominance of cell growth stimulatory effects of interferon-gamma due to phosphorylation of Stat1 and Stat3. Blood 1997 1.03
9 Nitric oxide suppression of human hematopoiesis in vitro. Contribution to inhibitory action of interferon-gamma and tumor necrosis factor-alpha. J Clin Invest 1995 1.03
10 OPSI threat in hematological patients. Transl Med UniSa 2013 0.99
11 Expression and modulation of cellular receptors for interferon-gamma, tumour necrosis factor, and Fas on human bone marrow CD34+ cells. Br J Haematol 1997 0.97
12 Effects of various antireabsorptive treatments on bone mineral density in hypogonadal young women after allogeneic stem cell transplantation. Bone Marrow Transplant 2006 0.96
13 Therapy of molecular relapse in acute promyelocytic leukemia. Blood 1999 0.94
14 BCR/ABL mRNA and the P210(BCR/ABL) protein are downmodulated by interferon-alpha in chronic myeloid leukemia patients. Blood 1999 0.92
15 Successful treatment of a patient with a thymoma and pure red-cell aplasia with octreotide and prednisone. N Engl J Med 1997 0.91
16 Expression of the 67-kDa laminin receptor in acute myeloid leukemia cells mediates adhesion to laminin and is frequently associated with monocytic differentiation. Clin Cancer Res 1999 0.91
17 Fine needle aspiration cytology of lymphoproliferative lesions of the oral cavity. Cytopathology 2014 0.89
18 Interleukin-2 therapy in relapsed acute myelogenous leukemia. Cancer J Sci Am 1997 0.88
19 Non lymphomatous clonal B-Cell populations in enlarged lymph nodes in acquired immunodeficiency syndrome. Infez Med 2012 0.87
20 Desferioxamine increases iron depletion and apoptosis induced by ara-C of human myeloid leukaemic cells. Br J Haematol 1998 0.86
21 Achievements and limitations of complement inhibition by eculizumab in paroxysmal nocturnal hemoglobinuria: the role of complement component 3. Mini Rev Med Chem 2011 0.86
22 Sustained long-term hematologic recovery despite a marked quantitative defect in the stem cell compartment of patients with aplastic anemia after immunosuppressive therapy. Am J Hematol 2000 0.84
23 Unresponsiveness to erythropoietin therapy in a case of Blackfan Diamond anemia. Am J Hematol 1991 0.84
24 Spleen sizing by ultrasound scan and risk of pneumococcal infection in patients with chronic GVHD: preliminary observations. Bone Marrow Transplant 1999 0.83
25 Measurement of secondary colony formation after 5 weeks in long-term cultures in patients with myelodysplastic syndrome. Leukemia 1998 0.82
26 Impact of immunogenetic polymorphisms in bone marrow failure syndromes. Mini Rev Med Chem 2011 0.82
27 Hematopoietic inhibition by interferon-gamma is partially mediated through interferon regulatory factor-1. Blood 1995 0.82
28 Beneficial treatment with risedronate in long-term survivors after allogeneic stem cell transplantation for hematological malignancies. Osteoporos Int 2003 0.82
29 Donor lymphocyte infusion for post-transplant relapse of Hodgkin's lymphoma. Haematologica 2000 0.81
30 The urokinase-receptor in infectious diseases. Infez Med 2012 0.80
31 Low-dose valgancyclovir as cytomegalovirus reactivation prophylaxis in allogeneic haematopoietic stem cell transplantation. Infez Med 2012 0.80
32 Allogeneic bone marrow transplantation restores IGF-I production and linear growth in a gamma-SCID patient with abnormal growth hormone receptor signaling. Bone Marrow Transplant 2004 0.80
33 Successful management of pulmonary mucormycosis with liposomal amphotericin B and surgery treatment: a case report. Infez Med 2012 0.79
34 Identification and treatment of late onset Fanconi's anemia. Haematologica 1996 0.78
35 Prolonged response to cyclosporin-A in hypoplastic refractory anemia and correlation with in vitro studies. Haematologica 2000 0.77
36 Hp(2-20) peptide of Helicobacter pylori and the innate immune receptors: specific role(s) of the formyl peptide receptors. Infez Med 2012 0.77
37 Cryptozoospermia with normal testicular function after allogeneic stem cell transplantation: a case report. Hum Reprod 2006 0.77
38 Early detection by ultrasound scan of severe post-chemotherapy gut complications in patients with acute leukemia. Haematologica 1999 0.77
39 Prognostic irrelevance of CD34 in acute myeloid leukaemia. Br J Haematol 1992 0.76
40 Nitric oxide and cell survival: megakaryocytes say "NO". J Lab Clin Med 2001 0.76
41 [Splenectomy in idiopathic thrombocytopenic purpura]. Minerva Chir 1986 0.76
42 Danazol for myelodysplastic syndromes. Br J Haematol 1993 0.75
43 New insights into biological targets and therapeutic management of infectious diseases. Infez Med 2012 0.75
44 Porphyria cutanea tarda and hematological diseases. Am J Hematol 1988 0.75
45 Previous occurrence of life-threatening abdominal infection is not a contraindication to bone marrow transplantation. Haematologica 1999 0.75
46 Alpha interferon in the treatment of chronic myelomonocytic leukemia. Haematologica 1990 0.75
47 A further case of intracerebral tumor in AML. Haematologica 1989 0.75
48 Fanconi's anemia cells are relatively resistant to H2O2-induced damage. Haematologica 1998 0.75
49 Induction of alkaline phosphatase activity in chronic myeloid leukemia cells: in vitro studies and speculative hypotheses. Am J Hematol 1990 0.75
50 Ultrasound scan to detect acalculous cholecystopathy in immunocompromised hosts with unexplained fever. Haematologica 2000 0.75
51 A novel chromosomal abnormality detected in a case of acute myelomonocytic leukemia. Leukemia 1994 0.75
52 Alcohol and cephamandole. Haematologica 1986 0.75
53 Low-dose Ara-C as maintenance treatment in AML. Haematologica 1989 0.75
54 Low-dose interleukin-2 for treating postautologous transplant cytogenetic abnormality recurrency in a case of acute myeloid leukemia with hyperdiploidy. Blood 1998 0.75
55 In vitro photoinhibition by psoralen and ultraviolet A radiation of human hematopoietic progenitors. Photodermatol Photoimmunol Photomed 1996 0.75
56 Complete phenotypic and genotypic lineage switch in a Philadelphia chromosome-positive acute lymphoblastic leukemia. Leukemia 1996 0.75
57 Trisomy 13 in a patient with leukemic progression of myelodysplasia. Cancer Genet Cytogenet 1993 0.75
58 Lamivudine treatment for chronic replicative hepatitis B virus infection after allogeneic bone marrow transplantation. Bone Marrow Transplant 1998 0.75
59 Ultrasound image of pleural granulocytic sarcoma. Haematologica 1997 0.75